The Harvard Drug Group LLC recalls Memantine Hydrochloride Extended-Release
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications
- Products
-
- Memantine Hydrochloride Extended-Release
- Company
- The Harvard Drug Group LLC
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- N/A
- About this recall
- Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61